Item Type | Name |
Academic Article
|
Plasma concentrations of immunoreactive atrial natriuretic peptide in hospitalized cirrhotic and noncirrhotic patients: evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites.
|
Concept
|
Humans
|
Concept
|
Chromosomes, Human, Pair 19
|
Concept
|
Genome, Human
|
Concept
|
Hepatitis, Viral, Human
|
Academic Article
|
Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
|
Academic Article
|
Iron and the liver.
|
Academic Article
|
Activation of the hepatocarcinogen aflatoxin B1 by forms of human hepatic cytochromes P-450: some do and some don't.
|
Academic Article
|
A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function.
|
Academic Article
|
A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition.
|
Academic Article
|
Osteocalcin and bone alkaline phosphatase in the serum of women with liver disease.
|
Academic Article
|
Immunochemical studies of haem oxygenase. Preparation and characterization of antibodies to chick liver haem oxygenase and their use in detecting and quantifying amounts of haem oxygenase protein.
|
Academic Article
|
Cloning, sequencing and expression of cDNA for chick liver haem oxygenase. Comparison of avian and mammalian cDNAs and deduced proteins.
|
Academic Article
|
Purification and characterization of heme oxygenase from chick liver. Comparison of the avian and mammalian enzymes.
|
Academic Article
|
Antibodies against mitochondrial dehydrogenase complexes in primary biliary cirrhosis.
|
Academic Article
|
Four-hour measurement of urinary iron excretion after deferoxine treatment: a rapid, simple method for study of iron excretion.
|
Academic Article
|
Prevalence and prediction of osteopenia in chronic liver disease.
|
Academic Article
|
Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease.
|
Academic Article
|
Choline may be an essential nutrient in malnourished patients with cirrhosis.
|
Academic Article
|
The porphyrias.
|
Academic Article
|
Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda.
|
Academic Article
|
Microassay of heme oxygenase by high-performance liquid chromatography: application to assay of needle biopsies of human liver.
|
Academic Article
|
Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function.
|
Academic Article
|
Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defect.
|
Academic Article
|
Severe liver injury due to phenelzine with unique hepatic deposition of extracellular material.
|
Academic Article
|
Conversion of 5-aminolaevulinate into haem by homogenates of human liver. Comparison with rat and chick-embryo liver homogenates.
|
Academic Article
|
Effect of uroporphyrin on the spectral measurement of cytochrome P450.
|
Academic Article
|
Effect of hemochromatosis on hepatic cytochrome P450 and antipyrine metabolism in humans.
|
Academic Article
|
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
|
Academic Article
|
Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.
|
Academic Article
|
A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C.
|
Academic Article
|
Chronic leukocytoclastic vasculitis complicating HBV infection. Possible role of mutant forms of HBV in pathogenesis and persistence of disease.
|
Academic Article
|
Putting the freeze on hepatitis C virus-associated mixed cryoglobulinemia.
|
Academic Article
|
Colonic mucosal appearance of Tangier disease in a new patient.
|
Academic Article
|
The post-translational processing of myeloperoxidase is regulated by the availability of heme.
|
Academic Article
|
Inflammatory cloacogenic polyp: three cases and literature review.
|
Academic Article
|
Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency.
|
Academic Article
|
Induction of heme oxygenase in intestinal epithelial cells: studies in Caco-2 cell cultures.
|
Academic Article
|
Nutritional supplementation in chronic liver disease: an analytical review.
|
Academic Article
|
Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literature.
|
Academic Article
|
Advances in understanding and treating 'the little imitator,' acute porphyria.
|
Academic Article
|
Iron and chronic viral hepatitis: emerging evidence for an important interaction.
|
Academic Article
|
High-dose interferon-alpha 2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C. A controlled randomized trial.
|
Academic Article
|
Iron in liver diseases other than hemochromatosis.
|
Academic Article
|
Effect of interferon therapy on bile duct inflammation in hepatitis C.
|
Academic Article
|
An update on iron metabolism: summary of the Fifth International Conference on Disorders of Iron Metabolism.
|
Academic Article
|
Haemopexin and uptake of haem by liver cells.
|
Academic Article
|
Multiple chemical sensitivity syndrome and porphyria. A note of caution and concern.
|
Academic Article
|
Iron and chronic viral hepatitis.
|
Academic Article
|
Regulation of expression of the human heme oxygenase-1 gene in transfected chick embryo liver cell cultures.
|
Academic Article
|
Therapy of hepatitis C: other options.
|
Academic Article
|
Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study.
|
Academic Article
|
Inflammatory markers in chronic hepatitis C.
|
Academic Article
|
Frequency and distribution of DNA fragmentation as a marker of cell death in chronic liver diseases.
|
Academic Article
|
Diagnosis of porphyric syndromes: a practical approach in the era of molecular biology.
|
Academic Article
|
Management of acute attacks in the porphyrias.
|
Academic Article
|
Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
|
Academic Article
|
Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C.
|
Academic Article
|
Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C.
|
Academic Article
|
Porphyrin loading of lipofuscin granules in inflamed striated muscle.
|
Academic Article
|
Inefficient recognition of autologous viral sequences by intrahepatic hepatitis C virus-specific cytotoxic T lymphocytes in chronically infected subjects.
|
Academic Article
|
Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.
|
Academic Article
|
The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria.
|
Academic Article
|
Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques.
|
Academic Article
|
Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
|
Academic Article
|
IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy.
|
Academic Article
|
Heme oxygenase: recent advances in understanding its regulation and role.
|
Academic Article
|
Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration.
|
Academic Article
|
Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
|
Academic Article
|
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
|
Academic Article
|
Outcomes research in chronic viral hepatitis C: effects of interferon therapy.
|
Academic Article
|
Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis.
|
Academic Article
|
Zebrafish dracula encodes ferrochelatase and its mutation provides a model for erythropoietic protoporphyria.
|
Academic Article
|
Management of recurrent hepatitis C after liver transplantation: a concise review.
|
Academic Article
|
Hepatitis C: a review and update.
|
Academic Article
|
Hepatic iron concentration and total body iron stores in thalassemia major.
|
Academic Article
|
Iron-induced liver injury.
|
Academic Article
|
Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis.
|
Academic Article
|
Urea and hypertonicity increase expression of heme oxygenase-1 in murine renal medullary cells.
|
Academic Article
|
Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trial.
|
Academic Article
|
Extrahepatic manifestations of infection with hepatitis C virus.
|
Academic Article
|
Iron as a comorbid factor in chronic viral hepatitis.
|
Academic Article
|
Benefits of chronic plasmapheresis and intravenous heme-albumin in erythropoietic protoporphyria after orthotopic liver transplantation.
|
Academic Article
|
Intestinal expression of genes involved in iron absorption in humans.
|
Academic Article
|
Hemochromatosis and porphyria.
|
Academic Article
|
Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.
|
Academic Article
|
Management of nonalcoholic steatohepatitis: an analytic review.
|
Academic Article
|
Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
|
Academic Article
|
Optimal management of nonalcoholic fatty liver/steatohepatitis.
|
Academic Article
|
Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane.
|
Academic Article
|
Iron as a co-morbid factor in nonhemochromatotic liver disease.
|
Academic Article
|
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
|
Academic Article
|
Hepatic porphyrias: diagnosis and management.
|
Academic Article
|
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.
|
Academic Article
|
Role of Bach-1 in regulation of heme oxygenase-1 in human liver cells: insights from studies with small interfering RNAS.
|
Academic Article
|
Hemochromatosis mutations in Iranians with hepatitis B virus infection.
|
Academic Article
|
Fatal air and bile embolism after percutaneous liver biopsy and ERCP.
|
Academic Article
|
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C.
|
Academic Article
|
Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey.
|
Academic Article
|
Recommendations for the diagnosis and treatment of the acute porphyrias.
|
Academic Article
|
Evolution of the intrahepatic T cell repertoire during chronic hepatitis C virus infection.
|
Academic Article
|
Comparison of amplification enzymes for Hepatitis C Virus quasispecies analysis.
|
Academic Article
|
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.
|
Academic Article
|
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
|
Academic Article
|
No role of the -2518 promoter polymorphism of monocyte chemotactic protein-1 in chronic hepatitis C.
|
Academic Article
|
Neurovisceral porphyrias: what a hematologist needs to know.
|
Academic Article
|
Iron in nonhemochromatotic liver disorders.
|
Academic Article
|
Liver transplantation for erythropoietic protoporphyria liver disease.
|
Academic Article
|
Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis).
|
Academic Article
|
Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.
|
Academic Article
|
HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells.
|
Academic Article
|
Reconstitution of hematin for intravenous infusion.
|
Academic Article
|
Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern.
|
Academic Article
|
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
|
Academic Article
|
Autoimmune hepatitis triggered by statins.
|
Academic Article
|
Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin.
|
Academic Article
|
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
|
Academic Article
|
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
|
Academic Article
|
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.
|
Academic Article
|
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
|
Academic Article
|
Genetic aspects of porphyria cutanea tarda.
|
Academic Article
|
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
Marked hyperbilirubinemia associated with the heme oxygenase-1 gene promoter microsatellite polymorphism in a boy with autoimmune hemolytic anemia.
|
Academic Article
|
Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.
|
Academic Article
|
Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials.
|
Academic Article
|
Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes.
|
Academic Article
|
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
|
Academic Article
|
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
|
Academic Article
|
Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.
|
Academic Article
|
Vascular endothelium as a contributor of plasma sphingosine 1-phosphate.
|
Academic Article
|
Zinc mesoporphyrin induces rapid and marked degradation of the transcription factor Bach1 and up-regulates HO-1.
|
Academic Article
|
Case records of the Massachusetts General Hospital. Case 20-2008. A 57-year-old woman with abdominal pain and weakness after gastric bypass surgery.
|
Academic Article
|
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial.
|
Academic Article
|
Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration.
|
Academic Article
|
Effects of silymarin on hepatitis C virus and haem oxygenase-1 gene expression in human hepatoma cells.
|
Academic Article
|
Hereditary hemochromatosis: time for targeted screening.
|
Academic Article
|
Differential regulation of human ALAS1 mRNA and protein levels by heme and cobalt protoporphyrin.
|
Academic Article
|
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
|
Academic Article
|
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.
|
Academic Article
|
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
|
Academic Article
|
Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.
|
Academic Article
|
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.
|
Academic Article
|
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
|
Academic Article
|
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
|
Academic Article
|
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
|
Academic Article
|
CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA.
|
Academic Article
|
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.
|
Academic Article
|
Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.
|
Academic Article
|
Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial.
|
Academic Article
|
Drug-induced liver injury associated with statins.
|
Academic Article
|
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
|
Academic Article
|
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.
|
Academic Article
|
Zinc mesoporphyrin induces rapid proteasomal degradation of hepatitis C nonstructural 5A protein in human hepatoma cells.
|
Academic Article
|
Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C.
|
Academic Article
|
Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review.
|
Academic Article
|
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins.
|
Academic Article
|
Genetic variations in heme oxygenase-1 and chronic hepatitis.
|
Academic Article
|
A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment.
|
Academic Article
|
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.
|
Academic Article
|
Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
|
Academic Article
|
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
|
Academic Article
|
Discovery of putative pancreatic cancer biomarkers using subcellular proteomics.
|
Academic Article
|
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis.
|
Academic Article
|
Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.
|
Academic Article
|
Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus.
|
Academic Article
|
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
|
Academic Article
|
Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C.
|
Academic Article
|
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.
|
Academic Article
|
Structural analysis of heme proteins: implications for design and prediction.
|
Academic Article
|
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
|
Academic Article
|
Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV.
|
Academic Article
|
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
|
Academic Article
|
microRNAs: fad or future of liver disease.
|
Academic Article
|
Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells.
|
Academic Article
|
An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C.
|
Academic Article
|
Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.
|
Academic Article
|
Extended interferon-alpha therapy accelerates telomere length loss in human peripheral blood T lymphocytes.
|
Academic Article
|
Effects of a single dose of oral iron on hepcidin concentrations in human urine and serum analyzed by a robust LC-MS/MS method.
|
Academic Article
|
Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discovery.
|
Academic Article
|
Association of filamin A and vimentin with hepatitis C virus proteins in infected human hepatocytes.
|
Academic Article
|
YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.
|
Academic Article
|
A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture.
|
Academic Article
|
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
|
Academic Article
|
Serum proteomic profiling in patients with drug-induced liver injury.
|
Academic Article
|
Chinese medicine for treatment of chronic hepatitis B.
|
Academic Article
|
Hepatitis C, porphyria cutanea tarda and liver iron: an update.
|
Academic Article
|
Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C.
|
Academic Article
|
The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes.
|
Academic Article
|
Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series.
|
Academic Article
|
Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.
|
Academic Article
|
Identification of differentially expressed proteins from primary versus metastatic pancreatic cancer cells using subcellular proteomics.
|
Academic Article
|
Risk factors for porphyria cutanea tarda -the iron/HFE connection.
|
Academic Article
|
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.
|
Academic Article
|
Liver injury from tumor necrosis factor-a antagonists: analysis of thirty-four cases.
|
Academic Article
|
Cytoskeletal proteins: shaping progression of hepatitis C virus-induced liver disease.
|
Academic Article
|
Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria.
|
Academic Article
|
Presentation and outcomes with clinically apparent interferon beta hepatotoxicity.
|
Academic Article
|
Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient.
|
Academic Article
|
Heme status affects human hepatic messenger RNA and microRNA expression.
|
Academic Article
|
Catechins in dietary supplements and hepatotoxicity.
|
Academic Article
|
Circadian rhythms in acute intermittent porphyria--a pilot study.
|
Academic Article
|
Porphyrin and heme metabolism and the porphyrias.
|
Academic Article
|
Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection.
|
Academic Article
|
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
|
Academic Article
|
Proteomic strategy for probing complementary lethality of kinase inhibitors against pancreatic cancer.
|
Academic Article
|
Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
|
Academic Article
|
Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance.
|
Academic Article
|
Novel role of nuclear receptor Rev-erba in hepatic stellate cell activation: potential therapeutic target for liver injury.
|
Academic Article
|
Hepatotoxicity of anti-TNF agents.
|
Academic Article
|
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
|
Academic Article
|
Drug-induced liver injury with autoimmune features.
|
Academic Article
|
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.
|
Academic Article
|
Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium.
|
Academic Article
|
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
|
Academic Article
|
Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome.
|
Academic Article
|
MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.
|
Academic Article
|
Herbal products and the liver: a review of adverse effects and mechanisms.
|
Academic Article
|
On stress and the liver: a chicken and egg conundrum.
|
Academic Article
|
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
|
Academic Article
|
Afamelanotide for Erythropoietic Protoporphyria.
|
Academic Article
|
Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.
|
Academic Article
|
Acute Porphyrias.
|
Academic Article
|
Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.
|
Academic Article
|
Homeostasis of iron and hepcidin in erythropoietic protoporphyria.
|
Academic Article
|
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
|
Academic Article
|
Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy.
|
Academic Article
|
Pitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and Monitoring of Protoporphyrias.
|
Academic Article
|
Recent insights into the biological functions of liver fatty acid binding protein 1.
|
Academic Article
|
Hepatotoxicity Associated with the Use of Anti-TNF-a Agents.
|
Academic Article
|
Amoxicillin-Clavulanate-Induced Liver Injury.
|
Academic Article
|
Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.
|
Academic Article
|
Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance.
|
Academic Article
|
BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial-mesenchymal transition via upregulating ID2.
|
Academic Article
|
Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.
|
Academic Article
|
Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury.
|
Academic Article
|
Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response.
|
Grant
|
Research Network for Drug-Induced Liver Disease
|
Grant
|
Regulation of Hepatic Heme Metabolism
|
Grant
|
Effect of Heme on mRNA and miRNA Profile
|
Academic Article
|
Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
|
Academic Article
|
Acute hepatic porphyrias: Recommendations for evaluation and long-term management.
|
Academic Article
|
Porphyria.
|
Academic Article
|
BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma.
|
Academic Article
|
miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling.
|
Academic Article
|
Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.
|
Academic Article
|
Peripheral Neuropathy and the Ceruloplasmin Gene.
|
Academic Article
|
Reply.
|
Academic Article
|
Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Cav3.2?T-type voltage-gated calcium channels and Ca2+ influx.
|
Academic Article
|
Porphyrin-Induced Protein Oxidation and Aggregation as a Mechanism of Porphyria-Associated Cell Injury.
|
Academic Article
|
Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group.
|
Academic Article
|
Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).
|
Academic Article
|
International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyrias.
|
Academic Article
|
Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.
|
Academic Article
|
Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias.
|
Academic Article
|
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria.
|
Academic Article
|
Strong correlation of ferrochelatase enzymatic activity with Mitoferrin-1 mRNA in lymphoblasts of patients with protoporphyria.
|